Acadia Healthcare Company, Inc. (ACHC) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $26.56. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ACHC = $4.67 (-82.4% from the current price, the stock appears overvalued). Analyst consensus target is ACHC = $20 (-25.4% upside).
Valuation: ACHC trades at a trailing Price-to-Earnings (P/E) of -2.2 (S&P 500 average ~25).
Financials: revenue is $3.3B, +8.3%/yr average growth. Net income is $1.1B (loss), growing at +213.5%/yr. Net profit margin is -33.3% (negative). Gross margin is 17.6% (-25.2 pp trend).
Balance sheet: total debt is $2.7B against $1.9B equity (Debt-to-Equity (D/E) ratio 1.36, moderate). Current ratio is 1.55 (strong liquidity). Debt-to-assets is 48%. Total assets: $5.5B.
Analyst outlook: 16 / 25 analysts rate ACHC as buy (64%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 10/100 (Fail), Growth 83/100 (Pass), Past 50/100 (Partial), Health 50/100 (Partial), Moat 31/100 (Fail), Future 37/100 (Fail), Income 10/100 (Fail).
